Cyclosporin A inhibits calcineurin (phosphatase 2B) and P-glycoprotein activity in Entamoeba histolytica

International Journal for Parasitology

Volumn 34, Issue 9, 2004, Pages 1091-1097

  Carrero, Julio C ^a   Lugo, Haydee ^a   Pérez, D Guillermo ^b   Ortiz Martínez, César ^a   Laclette, Juan P ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Calcineurin; Cyclosporin A; Entamoeba histolytica; Immunosuppressor; P glycoprotein; PSC 833

Indexed keywords

ASPARTYLLEUCYLASPARTYLVALYLPROLYLISOLEUCYLPROLYLGLYCYLARGINYLPHENYLALANYL ASPARTYLARGINYLARGINYLVALYL 4 SERYLVALYLALANYLALANYLGLUTAMINE; CALCINEURIN; CYCLOSPORIN A; EMETINE; GLYCOPROTEIN; PHOSPHOPEPTIDE; RHODAMINE; TACROLIMUS; UNCLASSIFIED DRUG; VALSPODAR;

DRUG DEVELOPMENT; PARASITOLOGY;

AMEBIASIS; ARTICLE; CONTROLLED STUDY; ENTAMOEBA HISTOLYTICA; ENZYME ACTIVITY; ENZYME INHIBITION; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TROPHOZOITE;

ANIMALS; ANTIPROTOZOAL AGENTS; CALCINEURIN; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTAMOEBA HISTOLYTICA; IMMUNOSUPPRESSIVE AGENTS; P-GLYCOPROTEIN; PHOSPHORIC MONOESTER HYDROLASES; RHODAMINES; TACROLIMUS;

ENTAMOEBA; ENTAMOEBA HISTOLYTICA; PROTOZOA;

EID: 4143049147     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2004.05.004     Document Type: Article

References (29)

1. Bañuelos C., Orozco E., Gómez C., González A., Medel O., Mendoza L., Pérez D.G. Cellular location and function of the P-glycoproteins (EhPgps) in Entamoeba histolytica multidrug-resistant trophozoites. Microb. Drug Resist. 8:2002;291-300
2. Borel J.F., Baumann G., Chapman I., Donatsch P., Fahr A., Mueller E.A., Vigouret J.M. In vivo pharmacological effects of cyclosporin and some analogues. Adv. Pharmacol. 35:1996;115-246
3. Carrero J.C., Petrossian P., Olivos A., Sánchez-Zerpa M., Ostoa-Saloma P., Laclette J.P. Effect of Cyclosporin A on Entamoeba histolytica. Arch. Med. Res. 31:2000;S8-S9
4. Chappell L.H., Wastling J.M. Cyclosporin A: antiparasite drug, modulator of the host-parasite relationship and immunosuppressant. Parasitology. 105:1992;S25-S40
5. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:1992;695-697
6. Cohen P., Klumpp S., Schelling D.L. An improved procedure for identifying and quantitatin protein phosphatases in mammalian tissues. FEBS Lett. 250:1989;596-600
7. Demeule M., Wengers R.M., Beliveau R. Molecular interactions of cyclosporin A with P-glycoprotein. Photolabeling with cyclosporin derivatives. J. Biol. Chem. 272:1997;6647-6652
8. Descoteaux S., Ayala P., Samuelson J., Orozco E. Increase in mRNA of multiple EhPgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene. 164:1995;179-184
9. Diamond L.S., Harlow D.R., Cunnick C.C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans. R. Soc. Trop. Med. Hyg. 72:1978;431-432
10. Dobson S., May T., Berriman M., Del Vecchio C., Fairlamb A.H., Chakrabarti D., Barik S. Characterization of protein Ser/Thr phosphatases of the malaria parasite, Plasmodium falciparum: inhibition of the parasitic calcineurin by cyclophilin-cyclosporin complex. Mol. Biochem. Parasitol. 99:1999;167-181
11. Harding M.W., Galat A., Uehling D.E., Schreiber S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptydil-prolyl isomerase. Nature. 341:1989;758-760
12. Huai Q., Ke H. Structures of calcineurin and its complexes with immunophilins-immunosuppressants. Biochem. Biophys. Res. Commun. 311:2003;1095-1102
13. Huai Q., Kim H.J., Liu Y., Zhao Y., Mondragón A., Liu J.O., Ke H. Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc. Natl. Acad. Sci. USA. 99:2002;12037-12042
14. Khattab A., Pica-Mattoccia L., Wenger R., Cioli D., Klinkert M.Q. Assay of Schistosoma mansoni calcineurin phosphatase activity and assessment of its role in parasite survival. Mol. Biochem. Parasitol. 99:1999;269-273
15. Kissinger C.R., Parge H.E., Knighton D.R., Lewis C.T., Pelletier L.A., Tempczyk A., Kalish V.J., Tucker K.D., Showalter R.E., Moomaw E.W., Gastinel L.N., Habuka N., Chen X., Maldonada F., Barker J.E., Bacquet R., Villafranca J.E. Crystal structure of human calcineurin and the human FKBP12-FK506- calcineurin complex. Nature. 378:1995;641-644
16. Liu J. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol. Today. 14:1993;290-295
17. Liu J., Farmer J., Lane W., Friedman J., Weissman I., Schreiber S. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815
18. Loor F. Valspodar: current status and perspectives. Expert. Opin. Investig. Drugs. 8:1999;807-835
19. Martin B., Pallen C.J., Wang J.H., Graves D.J. Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphate activity of calcineurin. J. Biol. Chem. 260:1985;14932-14937
20. Orozco E., Cruz-Hernández F., Rodríguez M.A. Isolation and characterization of Entamoeba histolytica mutants resistant to emetine. Mol. Biochem. Parasitol. 15:1985;49-59
21. Ostoa-Saloma P., Carrero J.C., Petrossian P., Herión P., Landa A., Laclette J.P. Cloning, characterization and functional expression of a cyclophilin of Entamoeba histolytica. Mol. Biochem. Parasitol. 107:2000;219-225
22. Page A.P., Kumar S., Carlow C.K.S. Parasite cyclophilins and antiparasite activity of cyclosporin A. Parasitol. Today. 11:1995;385-388
23. Perkins M.E., Wu T.W., Le Blancq S.M. Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum. Antimicrob. Agents Chemother. 42:1998;843-848
24. Serra E.C., Lardans V., Dissous C. Identification of NF-AT-like transcription factor in Schistosoma mansoni: it's possible involvement in the antiparasitic action of cyclosporin A. Mol. Biochem. Parasitol. 101:1999;33-41
25. Shenolikar S., Ingebritsen T.S. Protein (serine and threonine) phosphate phosphatases. Methods Enzymol. 107:1984;102-129
26. Shustik C., Dalton W., Gros P. P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation. Mol. Aspects Med. 16:1995;1-78
27. Siekierka J.J., Hung S.H.Y., Poe M., Lin C.S., Sigal N.H. A cytosolic binding protein for the immunosuppressant FK506 has a peptidyl-prolyl isomerase activity but is distinct form cyclophilin. Nature. 341:1989;755-757
28. Silverman J.A., Hayes M.L., Luft B.J., Joiner K.A. Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P-glycoprotein in Toxoplasma physiology. Antimicrob. Agents Chemother. 41:1997;1859-1866
29. Tiberghien F., Wenandy T., Loor F. The potent immunosuppressive cyclosporin FR901459 inhibits the human P-glycoprotein and formyl peptide receptor functions. J. Antibiot. 53:2000;509-515